circRNA basic information
circBase ID: hsa_circ_0006984
Name: hsa_circ_ZNF79
Synonym: circZNF79(5) / circZNF79
Host Gene: ZNF79
Genomic location(hg19): chr9:130206307-130207528:+
Genomic location(hg38): chr9:127444028-127445249:+
Subcellular localization: cytoplasm
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tissues; adjacent normal tissues; serum exosomes; tumor tissues

Cell lines:

Huh7; HepG2; Bel-7402; MHCC-97H; HepG2-Luc

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: YBX1, BRCC36, p62, AGO2, HIF-1alpha
Associated microRNA: -
Biological function: Promotes HCC cell proliferation, migration, invasion and tumor growth; inhibits apoptosis.
Molecular mechanism: Binds YBX1 and recruits BRCC36 to deubiquitinate (K63-linked) and stabilize YBX1, preventing p62-mediated selective autophagic degradation via AMPK/mTOR; activates HIF-1 signaling pathway.
Biological pathway or process:

proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); autophagy (inhibits); AMPK (inhibits); PI3K/AKT/mTOR (other); HIF-1 signaling (promotes); ubiquitination (inhibits); selective autophagy (inhibits); ceRNA regulation (other)

Detected method:
Q
H
M
Validation methods:

Microarray; Bioinformatics Analysis; RT-qPCR; FISH / smFISH; divergent primers PCR; Sanger Sequencing; RNase R Treatment; Actinomycin D / DRB Stability Assay; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RNA Pull-Down; RIP (RNA Immunoprecipitation); Co-IP; Transfection; CCK8; Colony Formation Assay; EdU Staining; Cell Cycle Assay; Transwell Assay; Annexin V/PI Flow Cytometry; Western Blot; IF (Immunofluorescence); In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Survival Analysis

Clinical significance:

Upregulated in HCC tissues and serum exosomes; associated with advanced tumor stages (Stage III-IV) and poor prognosis.

Description:

circZNF79(5) is upregulated in HCC tissues and serum exosomes and is mainly localized in the cytoplasm. It promotes HCC proliferation/migration/invasion and inhibits apoptosis by binding YBX1 and recruiting BRCC36 to remove K63-linked ubiquitin chains, stabilizing YBX1 and enhancing downstream HIF-1 signaling, while preventing p62-mediated selective autophagic degradation of YBX1 via AMPK/mTOR.

Confidence score:

0.8933

Other information
Title:

Dysregulation of CircZNF79(5) Modulates YBX1 Stability and Selective Autophagy to Drive Hepatocellular Carcinoma Progression.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: 2026
PubMed ID: 41221627
Study type:

combined biological and clinical study

Data availability: GSE166678; exoRBase2.0
Code availability: -